Founded Year

1891

Stage

Corporate Minority - P2P | IPO

Market Cap

230.65B

Stock Price

92.92

Revenue

$0000 

About Merck

Merck operates as a biopharmaceutical company focused on developing medicines and vaccines. The company provides products for preventing and treating various diseases in humans and animals, including oncology, infectious diseases, cardio-metabolic disorders, immunology, neuroscience, and ophthalmology. Merck also utilizes data science and artificial intelligence in their therapeutic approaches. Merck was formerly known as Schering Plough. It was founded in 1891 and is based in Rahway, New Jersey.

Headquarters Location

126 East Lincoln Avenue

Rahway, New Jersey, 07065,

United States

908-740-4000

Loading...

Loading...

Research containing Merck

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Merck in 2 CB Insights research briefs, most recently on Jul 3, 2025.

Expert Collections containing Merck

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Merck is included in 1 Expert Collection, including HLTH 2025 Exhibitors.

H

HLTH 2025 Exhibitors

878 items

A look at the HLTH Vegas 2025 exhibitor list we’ve been building so your team can start scanning for relevant companies.

Merck Patents

Merck has filed 5635 patents.

The 3 most popular patent topics include:

  • transcription factors
  • clusters of differentiation
  • monoclonal antibodies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/23/2020

4/8/2025

Multiple sclerosis, Autoimmune diseases, Pharmacokinetics, Dosage forms, Antineoplastic drugs

Grant

Application Date

10/23/2020

Grant Date

4/8/2025

Title

Related Topics

Multiple sclerosis, Autoimmune diseases, Pharmacokinetics, Dosage forms, Antineoplastic drugs

Status

Grant

Latest Merck News

Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline

Nov 16, 2025

Cidara’s lead pipeline candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza. CD388 consists of a small molecule neuraminidase inhibitor stably conjugated to a proprietary Fc fragment of a human antibody designed to prevent influenza A and B. The post Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline  appeared first on GEN - Genetic Engineering and Biotechnology News.

Merck Frequently Asked Questions (FAQ)

  • When was Merck founded?

    Merck was founded in 1891.

  • Where is Merck's headquarters?

    Merck's headquarters is located at 126 East Lincoln Avenue, Rahway.

  • What is Merck's latest funding round?

    Merck's latest funding round is Corporate Minority - P2P.

  • Who are the investors of Merck?

    Investors of Merck include Blackstone.

  • Who are Merck's competitors?

    Competitors of Merck include Viatris, AbbVie, Daiichi Sankyo, Sanofi, Bayer and 7 more.

Loading...

Compare Merck to Competitors

Novartis Logo
Novartis

Novartis develops and offers a range of medicines aimed at treating serious diseases, providing support for patients and healthcare professionals, and conducting research to discover new therapies. The company also focuses on environmental sustainability and ethical practices in the pharmaceutical industry. It was founded in 1996 and is based in Basel, Switzerland.

Servier Logo
Servier

Servier operates as a pharmaceutical company, engages in the research, development, and production of medications for various diseases, including targeted therapies for cancer, cardiovascular treatments, diabetes, and drugs for immuno-inflammatory and neuropsychiatric conditions. The company also produces generic drugs. It was founded in 1954 and is based in Suresnes, France.

B
Boehringer Ingelheim

Boehringer Ingelheim operates within the pharmaceutical and animal health sectors. The company conducts research and development of products for humans and animals. Boehringer Ingelheim serves the healthcare industry with an emphasis on pharmaceutical products. It was founded in 1885 and is based in Ingelheim am Rhein, Germany.

Bristol-Myers Squibb Logo
Bristol-Myers Squibb

Bristol-Myers Squibb operates as a biopharmaceutical company involved in the discovery, development, and delivery of medicines across various therapeutic areas. The company specializes in treatments for oncology, hematology, immunology, cardiovascular disease, and fibrosis, utilizing translational medicine and data analytics. Bristol-Myers Squibb also engages in health equity initiatives through its foundation to improve health outcomes for populations affected by serious diseases. It was founded in 1887 and is based in Princeton, New Jersey.

S
Sumitomo Pharma

Sumitomo Pharma is a biopharmaceutical company focused on developing therapeutic and scientific breakthroughs. The company's main offerings include the development of novel cancer therapeutics and a robust pipeline of treatments aimed at addressing unmet clinical needs in oncology. Sumitomo Pharma was formerly known as Sumitomo Dainippon Pharma. It was founded in 1897 and is based in Osaka, Japan.

T
Teva México

Teva México specializes in the pharmaceutical industry, focusing on the development and manufacturing of generic medications. The company offers a range of generic medicines designed to improve health outcomes for patients. Teva México primarily serves the healthcare sector by providing medication options. It is based in Ciudad de México, Mexico.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.